Penetrance: does the gene show at all?
A clean Punnett square predicts genotypes, but the visible phenotype does not always follow. Penetrance asks a yes/no question across a group: of everyone who carries a particular genotype, what fraction actually shows the trait? If only 80 out of 100 people with an autosomal-dominant allele develop the condition, the allele is said to have 80% penetrance — it is *incompletely penetrant*.
Expressivity: how strongly does it show?
Where penetrance is yes-or-no, expressivity is a dial. Among the people who *do* show a trait, expressivity measures how *severely* or *variably* it shows. Two relatives with the very same genotype might have wildly different experiences — one barely affected, another markedly so. Variable expressivity is common, and it often reflects modifier genes, chance during development, and gene–environment interaction.
Same allele, two different questions:
PENETRANCE = of all carriers, what % show ANYTHING?
(yes / no, counted across the group)
EXPRESSIVITY = among those who DO show it,
HOW MUCH / how severely? (a range)
Example (autosomal dominant, 100 people carry the allele):
- 90 show some sign -> penetrance = 90%
- of those 90: a few mild, many moderate, some severe
-> variable expressivityPleiotropy: one gene, many ripples
Pleiotropy flips the usual question around: instead of many genes shaping one trait, a *single* gene affects *many* seemingly unrelated traits. A clear example is sickle-cell disease, where one change in the hemoglobin gene reshapes red blood cells and then ripples outward — pain crises, anemia, organ effects, and even some resistance to malaria all trace to the same allele. Pleiotropy reminds us that a gene's product can be used in many places at once, so one variant has consequences far beyond its 'main' effect.